High levels of scarlet fever remain across England

Public Health England (PHE) has reported a continuation of the high levels of scarlet fever across the country with 405 new cases reported in the last week (from 21 to 27 April). A total...

The Northern biomedical sector celebrated at prestigious awards ceremony

The best of the North of England’s biomedical companies were honoured at the 2014 Biomedical Awards, hosted by Bionow at the BALTIC Centre for Contemporary Art, on Gateshead Quays on 24 April 2014. Sixteen companies battled...

Initiative targets research into type 1 diabetes

Charity JDRF and UK Prime Minister David Cameron are supporting a push for ground-breaking type 1 diabetes stem-cell research partnerships between the UK and Israel. Mr Cameron announced plans for BIRAX (the Britain Israel Research...

Deal helps two North East firms gain a bigger bite of the market

North East teeth whitening company WhiteWash Laboratories has signed a deal with one of the UK’s largest dental labs, Ashford Orthodontics Ltd, in an agreement that could be worth up to £100,000 a year. WhiteWash,...

Ayrshire Life Science Company Launch Advanced Scientific Technology to Support Successful Drug Development

AvantiCell Science is a life science company based in Ayr, with a mission to provide leading-edge ethical tools which offer the prospect of faster, more efficient progress towards better drugs, safer chemotherapy, and improved...

Sumatra’s tigers defy expectations on genetic diversity

 A joint study led by scientists from international conservation charity ZSL (Zoological Society of London) in collaboration with Imperial College London and Panthera, the global wild cat conservation organization, has revealed that despite low...

Research deepens understanding of eczema

A research programme into genetics has identified new forms of the skin condition eczema and provided useful information that may lead to new treatments. The work involves 16 researchers across four schools at the University...

Brand new blending facility at Brenntag Lutterworth

Brenntag Blending Solutions has expanded with a brand new state-of-the art facility at Brenntag Lutterworth, providing additional blending capabilities across the Middle and South of the UK. The multi-purpose vessel has a 25,000L capacity and...

Targetting fast-growing cancer cells

The discovery that an essential protein plays a protective role during cell division, could open the door to better targeted treatment of fast-growing cancer cells. Polo-like kinase (PLK1) was previously thought to have a major...

Find out why County Durham’s NETPark is quickly becoming a global hub for bio-science...

Home to two UK catapult centres, three national innovation centres and one of the country’s leading AIM listed tech companies, The North East Technology Park (NETPark) really is a thriving hub of innovation making...

Compulsory licensing of pharmaceuticals: A solution to high drug prices?

The UK continues to grapple with its departure – or not – from the European Union, and whilst the outcome remains unclear, one thing now seems certain: before long there will be a general...

Research ‘must be allowed to thrive’

The Parkinson’s Disease Society has embarked on a new drive to ensure that research into the illness, and other conditions, continues to be supported across Europe. As part of the campaign, which is hosted by...

New Horizons in Life Science & Healthcare

Building on the evolution of the past 18 years, Genesis 2019 will assemble senior executives and decision makers from across the Life Science, Healthcare and Technology field to present, discuss and demonstrate their collective...

Rheumatology drugs study

Researchers at the Royal National Hospital for Rheumatic Diseases (RNHRD) in Bath, part of the Royal United Hospitals Bath NHS Foundation Trust, are celebrating recruiting the first patient globally to an international study that...

Edible insects: Mealworms on your menu?

Cricket brownies and “chocolate chirp cookies” were served at a meeting about the future of edible insects. Insects are eaten in many parts of the world, and if people in countries such as the UK...

Nemera to acquire Copernicus to boost parenteral product portfolio and small series capabilities

This acquisition strengthens Nemera’s proprietary product offering and establishes operations footprint in Eastern Europe. Nemera today announced that they have entered into an agreement to acquire Copernicus. Copernicus, based in Szczecin Poland, specializes in the...